Co-Existence of Adult-Onset Still’s Disease and IgA Nephropathy

Co-Existence of Adult-Onset Still’s Disease and IgA Nephropathy

Bibliographic Details
Main Authors:	Zeki Aydın, Özger Akarsu, Yonca Çağatay
Format:	Article
Language:	English
Published:	Galenos Yayinevi 2010-09-01
Series:	Haseki Tıp Bülteni
Subjects:	Adult-onset Still’s disease hematuria IgA nephropathy
Online Access:	http://www.hasekidergisi.com/makale_4581/Eriskin-Still-Hastaligi-Ve-Iga-Nefropatisi-Birlikteligi-Olgu-Sunumu

Similar Items

Iga nephropathy
by: Basta-Jovanović Gordana M.
Published: (2004-01-01)

Tonsillectomy Monotherapy for IgA Nephropathy: A Case SeriesPlain-Language Summary
by: Hirokazu Marumoto, et al.
Published: (2020-09-01)

Outcome of 313 Czech Patients With IgA Nephropathy After Renal Transplantation
by: Dita Maixnerova, et al.
Published: (2021-09-01)

Iga nephropathy: clinical-morphologic correlation
by: Basta-Jovanović Gordana M., et al.
Published: (2003-01-01)

The case of nutcracker phenomenon associated with IgA nephropathy
by: Medin Danilo V., et al.
Published: (2021-01-01)

Time-Averaged Hematuria as a Prognostic Indicator of Renal Outcome in Patients with IgA Nephropathy
by: Mengjie Weng, et al.
Published: (2022-11-01)

Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
by: Yoshihito Nihei, et al.
Published: (2023-04-01)

IgA Vasculitis and IgA Nephropathy: Same Disease?
by: Evangeline Pillebout
Published: (2021-05-01)

Podocytes are likely the therapeutic target of IgA nephropathy with isolated hematuria: Evidence from repeat renal biopsy
by: Mian-Na Luo, et al.
Published: (2023-04-01)

An Update on the Current State of Management and Clinical Trials for IgA Nephropathy
by: Chee Kay Cheung, et al.
Published: (2021-06-01)

Predictors of prognosis in IgA nephropathy
by: Yasuhiko Tomino
Published: (2012-10-01)

History of IgA Nephropathy Mouse Models
by: Batoul Wehbi, et al.
Published: (2021-07-01)

Clinical Relevance of Serum Galactose Deficient IgA1 in Patients with IgA Nephropathy
by: Jin Sug Kim, et al.
Published: (2020-11-01)

IgA nephropathy relapse following COVID-19 vaccination treated with corticosteroid therapy: case report
by: Shota Watanabe, et al.
Published: (2022-04-01)

IgA Nephropathy Associated with IgA Vasculitis Coexisting with Focal Segmental Glomerulosclerosis Tip Variant
by: Zitlali Guadalupe Paulín Zepeda, et al.
Published: (2023-07-01)

Characteristics of patients with coexisting IgA nephropathy and membranous nephropathy
by: Pei Chen, et al.
Published: (2018-10-01)

IgA nephropathy after COVID-19 vaccination and analysis of reported cases
by: Akira Mima, et al.
Published: (2023-06-01)

Nefropatia por IgA em portadores de espondiloartrites acompanhados no Serviço de Reumatologia do Hospital das Clínicas da UFMG IgA nephropathy in patients with spondyloarthritis followed-up at the Rheumatology Service of Hospital das Clínicas/UFMG
by: Daniela Castelo Azevedo, et al.
Published: (2011-10-01)

Glomerular Galactose-Deficient IgA1(KM55) Positive May Predict Poorer Prognosis in Coexisting Primary Membranous Nephropathy and IgA Nephropathy Patients
by: Wenrong Cheng, et al.
Published: (2022-12-01)

Alport syndrome misdiagnosed with IgA nephropathy from familial history: a case report and brief review
by: Hormat Rahimzadeh, et al.
Published: (2023-04-01)

Galactose-Deficient IgA1 as a Candidate Urinary Marker of IgA Nephropathy
by: Yusuke Fukao, et al.
Published: (2022-06-01)

Monitoring Immune Responses in IgA Nephropathy: Biomarkers to Guide Management
by: Haresh Selvaskandan, et al.
Published: (2020-10-01)

Supportive Management of IgA Nephropathy With Renin-Angiotensin Blockade, the AIIMS Primary IgA Nephropathy Cohort (APPROACH) Study
by: Soumita Bagchi, et al.
Published: (2021-06-01)

Aberrantly Glycosylated IgA1 in IgA Nephropathy: What We Know and What We Don’t Know
by: Yukako Ohyama, et al.
Published: (2021-08-01)

Comparative study on clinicopathological features and prognosis of IgA vasculitis nephritis and IgA nephropathy in children
by: Yan Lv, et al.
Published: (2023-08-01)

Inhibition of STAT3 Signaling Reduces IgA1 Autoantigen Production in IgA Nephropathy
by: Koshi Yamada, et al.
Published: (2017-11-01)

The pathogenesis of COVID-19-induced IgA nephropathy and IgA vasculitis: A systematic review
by: Hareem Farooq, MBBS, et al.
Published: (2022-02-01)

An Update on Current Therapeutic Options in IgA Nephropathy
by: Regina Shaoying Lim, et al.
Published: (2024-02-01)

Relapses or de-novo IgA nephropathy following COVID-19 vaccination; a narrative review
by: Masoud Hafizi, et al.
Published: (2023-03-01)

Pathogenic role of glycan-specific IgG antibodies in IgA nephropathy
by: Yan-feng Zhao, et al.
Published: (2017-09-01)

Characteristics of renal pathology and coagulation function in IgA nephropathy and IgA vasculitis associated nephritis
by: Yinhong Wang, et al.
Published: (2024-01-01)

Role of telitacicept in the treatment of IgA nephropathy
by: Lijun Wu, et al.
Published: (2023-09-01)

Management of IgA Nephropathy in Pediatric Patients
by: Sophie Schroda, et al.
Published: (2022-05-01)

Gross Hematuria Following SARS-CoV-2 Infection in IgA Nephropathy: A Report of 5 Cases
by: Hiroyuki Ueda, et al.
Published: (2023-06-01)

The clinical and pathological characteristics of IgA nephropathy patients in Tibet
by: Fenglei Si, et al.
Published: (2022-07-01)

IgA nephropathy in Kerala, India: A retrospective study
by: Chandrika B
Published: (2009-01-01)

Is There a Role for Gut Microbiome Dysbiosis in IgA Nephropathy?
by: Renato C. Monteiro, et al.
Published: (2022-03-01)

Mitofusin2 expression is associated with podocyte injury in IgA nephropathy
by: Xuanli Tang, et al.
Published: (2023-03-01)

Use of low-dose sulodexide in IgA nephropathy patients on renin–angiotensin system blockades
by: Byeong Yun Yang, et al.
Published: (2012-09-01)

IgA nephropathy: a review of existing and emerging therapies
by: Sahibzadi Mahrukh Noor, et al.
Published: (2023-05-01)